Omeros Corporation OMER
Regular-session close
After hours · Nov 20, 4:01 PM ET
- YTD
- -23.11%
- 1 year
- +60.51%
Held by funds
78 US ETFs and mutual funds hold OMER · largest positions
- VTI 0.00% of fund $31.57M
- IWM 0.04% of fund $27.34M
- NJM 0.02% of fund $16.36M
- VXF 0.02% of fund $15.18M
- FSSNX 0.04% of fund $14.84M
- BRNY 1.64% of fund $8.92M
- XPH 1.59% of fund $8.08M
- VTWO 0.04% of fund $7.82M
- FSMAX 0.02% of fund $6.31M
- IWN 0.05% of fund $6.19M
- SCHA 0.03% of fund $5.50M
- NLO 0.03% of fund $5.07M
- VFMO 0.25% of fund $4.91M
- BRES 0.70% of fund $4.16M
- VHT 0.02% of fund $3.91M
- IHE 0.22% of fund $3.76M
- IWO 0.03% of fund $3.73M
- IWC 0.28% of fund $3.22M
- BBP 2.29% of fund $2.92M
- FSKAX 0.00% of fund $2.66M
Ownership
- Institutions 52.6%
- Insiders 3.97%
- Public and other holders 43.5%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.35% | 6,046,101 | 84.71M | Sep 29, 2026 |
| Ingalls & Snyder LLC | 4.28% | 3,095,323 | 43.37M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.22% | 3,058,096 | 42.84M | Sep 29, 2026 |
| UBS Group AG | 4.10% | 2,970,107 | 41.61M | Sep 29, 2026 |
| State Street Corporation | 3.10% | 2,240,906 | 31.40M | Sep 29, 2026 |
| Geode Capital Management, LLC | 2.62% | 1,895,961 | 26.56M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.00% | 2,172,336 | 30.43M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.58% | 1,867,153 | 26.16M | Sep 29, 2026 |
| Invesco Exchange-Traded Fund Trust-Invesco Biotechnology & Genome ETF | 1.28% | 929,585 | 13.02M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.15% | 831,218 | 11.65M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.09% | 789,898 | 11.07M | Aug 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 0.74% | 533,750 | 7.48M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs OMER, and what each was last paid
Gregory A. Demopulos, Co-Founder, Chairman, Chief Executive Officer & PresidentAverage age 61
| Name | Title | Pay | Age |
|---|---|---|---|
| Gregory A. Demopulos | Co-Founder, Chairman, Chief Executive Officer & President | $1.97M | 67 |
| Peter Cancelmo | Vice President, General Counsel & Corporate Secretary | $665K | 47 |
| David J. Borges | Vice President of Finance, Chief Accounting Officer & Treasurer | $444K | 61 |
| William E. Woodman | Vice President & Chief Commercial Officer | — | — |
| Catherine A. Melfi | Chief Regulatory Officer & Vice President of Regulatory Affairs and Quality Systems | — | 67 |
| George A. Gaitanaris | Chief Scientific Officer & Vice President of Science | — | 69 |
| Peter W. Williams | Vice President of Human Resources | — | 58 |
| Pamela Pierce Palmer | Co-Founder | — | 63 |
| David W. Ghesquiere | Vice President & Chief Business Development Officer | — | 59 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BORGES DAVID J. | Officer | Sale | Sep 22, 2026 | 0 |
| CABLE THOMAS J | Director | Sale | Aug 19, 2026 | 35,067 |
| CANCELMO PETER B. | General Counsel | Sale | Aug 30, 2026 | 200 |
| DEMOPULOS GREGORY A. M.D. | Chief Executive Officer | Conversion of Exercise of derivative security | Feb 17, 2026 | 2,193,250 |
| HANISH ARNOLD C | Director | Sale | Aug 26, 2026 | 12,400 |
